RecallLookupBack to the product checker
Serious riskSerious risk

EU Safety Gate · Report-2019-028

Careprost · Bimatoprost ophthalmic solution

According to the label the product contains the active substance bimatoprost, which should be used under supervision of an ophthalmologist. Bimatoprost can cause eye and ophthalmic defects in the user and should not be used by pregnant and breastfeeding women, as it may affect the child. The product does not comply with the Cosmetic Products Regulation.

Published
12 July 2019
Notifying authority
Lithuania
Catalog checked
30 July 2026
What should you do?

Check the authority measure and original alert.

Type of economic operator to whom the measure(s) were ordered: Retailer. Category of measure(s): Withdrawal of the product from the market. Date of entry into force: 06/06/2019

Official source alert
Safety Gate reference
A12/1027/19
Model
0,03% w/v Sterile Eye drops, 3 ml
Batch
WBSOOl 1
Category
Cosmetics
Risk type
Chemical
Country of origin
India

White plastic bottle with dispenser cap containing ophthalmic solution.